Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations

Michaela Mayerova,1–3 Libor Ustohal,1–3 Jiri Jarkovsky,4 Jan Pivnicka,1,5 Tomas Kasparek,1,2 Eva Ceskova1,3 1Faculty of Medicine, Masaryk University, Brno, Czech Republic; 2Department of Psychiatry, University Hospital Brno, Brno, Czech Republic; 3CEITEC – Central Euro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/75752bf00b8c4972b24e89063afb13fe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:75752bf00b8c4972b24e89063afb13fe
record_format dspace
spelling oai:doaj.org-article:75752bf00b8c4972b24e89063afb13fe2021-12-02T02:01:58ZInfluence of dose, gender, and cigarette smoking on clozapine plasma concentrations1178-2021https://doaj.org/article/75752bf00b8c4972b24e89063afb13fe2018-06-01T00:00:00Zhttps://www.dovepress.com/influence-of-dose-gender-and-cigarette-smoking-on-clozapine-plasma-con-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Michaela Mayerova,1–3 Libor Ustohal,1–3 Jiri Jarkovsky,4 Jan Pivnicka,1,5 Tomas Kasparek,1,2 Eva Ceskova1,3 1Faculty of Medicine, Masaryk University, Brno, Czech Republic; 2Department of Psychiatry, University Hospital Brno, Brno, Czech Republic; 3CEITEC – Central European Institute of Technology, Masaryk University, Brno, Czech Republic; 4Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic; 5Institute of Forensic Medicine, St. Anne’s University Hospital, Masaryk University, Brno, Czech Republic Introduction: Therapeutic drug monitoring (TDM) of clozapine is a very useful method for verifying both the correct intake and the interindividual variability of its metabolism, thereby avoiding the risk of toxicity. The purposes of this paper were to discover how many patients using clozapine in common clinical practice have clozapine plasma concentration (PC) levels in the proposed reference range and to identify factors that influence clozapine PC levels. Methods: Our study included 100 inpatients (diagnosed with schizophrenia or schizoaffective disorder) taking standard doses of clozapine (100–700 mg/day). Clozapine concentration was measured by high-performance liquid chromatography. Correlations between doses and PC levels and the influence of smoking and gender on clozapine PC levels were calculated. Results: A large number of the patients (67%) had PC levels outside the proposed reference range. The clozapine PC levels were influenced by dose, gender, and cigarette smoking. Conclusion: The correlations between dose, gender, and cigarette smoking and clozapine PC levels highlighted by our study overlap other research. It was surprising to find such a large number of patients with clozapine PC levels outside the therapeutic range. This result suggests the importance of clozapine TDM due to misunderstood inter- and/or intraindividual variability or misestimated partial therapeutic compliance. Keywords: therapeutic drug monitoring, plasma levels, interindividual variability, schizophrenia, schizoaffective disorderMayerova MUstohal LJarkovsky JPivnicka JKasparek TCeskova EDove Medical Pressarticleclozapineplasma concentrationsdosegendersmokingNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 1535-1543 (2018)
institution DOAJ
collection DOAJ
language EN
topic clozapine
plasma concentrations
dose
gender
smoking
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle clozapine
plasma concentrations
dose
gender
smoking
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Mayerova M
Ustohal L
Jarkovsky J
Pivnicka J
Kasparek T
Ceskova E
Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
description Michaela Mayerova,1–3 Libor Ustohal,1–3 Jiri Jarkovsky,4 Jan Pivnicka,1,5 Tomas Kasparek,1,2 Eva Ceskova1,3 1Faculty of Medicine, Masaryk University, Brno, Czech Republic; 2Department of Psychiatry, University Hospital Brno, Brno, Czech Republic; 3CEITEC – Central European Institute of Technology, Masaryk University, Brno, Czech Republic; 4Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic; 5Institute of Forensic Medicine, St. Anne’s University Hospital, Masaryk University, Brno, Czech Republic Introduction: Therapeutic drug monitoring (TDM) of clozapine is a very useful method for verifying both the correct intake and the interindividual variability of its metabolism, thereby avoiding the risk of toxicity. The purposes of this paper were to discover how many patients using clozapine in common clinical practice have clozapine plasma concentration (PC) levels in the proposed reference range and to identify factors that influence clozapine PC levels. Methods: Our study included 100 inpatients (diagnosed with schizophrenia or schizoaffective disorder) taking standard doses of clozapine (100–700 mg/day). Clozapine concentration was measured by high-performance liquid chromatography. Correlations between doses and PC levels and the influence of smoking and gender on clozapine PC levels were calculated. Results: A large number of the patients (67%) had PC levels outside the proposed reference range. The clozapine PC levels were influenced by dose, gender, and cigarette smoking. Conclusion: The correlations between dose, gender, and cigarette smoking and clozapine PC levels highlighted by our study overlap other research. It was surprising to find such a large number of patients with clozapine PC levels outside the therapeutic range. This result suggests the importance of clozapine TDM due to misunderstood inter- and/or intraindividual variability or misestimated partial therapeutic compliance. Keywords: therapeutic drug monitoring, plasma levels, interindividual variability, schizophrenia, schizoaffective disorder
format article
author Mayerova M
Ustohal L
Jarkovsky J
Pivnicka J
Kasparek T
Ceskova E
author_facet Mayerova M
Ustohal L
Jarkovsky J
Pivnicka J
Kasparek T
Ceskova E
author_sort Mayerova M
title Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
title_short Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
title_full Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
title_fullStr Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
title_full_unstemmed Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
title_sort influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/75752bf00b8c4972b24e89063afb13fe
work_keys_str_mv AT mayerovam influenceofdosegenderandcigarettesmokingonclozapineplasmaconcentrations
AT ustohall influenceofdosegenderandcigarettesmokingonclozapineplasmaconcentrations
AT jarkovskyj influenceofdosegenderandcigarettesmokingonclozapineplasmaconcentrations
AT pivnickaj influenceofdosegenderandcigarettesmokingonclozapineplasmaconcentrations
AT kasparekt influenceofdosegenderandcigarettesmokingonclozapineplasmaconcentrations
AT ceskovae influenceofdosegenderandcigarettesmokingonclozapineplasmaconcentrations
_version_ 1718402784872628224